Demographic and clinical characteristics of dogs with centroblastic lymphoma
-
Published:2021
Issue:1
Volume:14
Page:49-55
-
ISSN:2231-0916
-
Container-title:January-2021
-
language:en
-
Short-container-title:Vet World
Author:
Kliczkowska-Klarowicz Katarzyna1ORCID, Jagielski Dariusz2, Czopowicz Michał3ORCID, Sapierzyński Rafał A.1ORCID
Affiliation:
1. Department of Pathology and Veterinary Diagnostics, Division of Pathology, Institute of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-776 Warsaw, Poland. 2. Białobrzeska Veterinary Surgery in Warsaw, Poland. 3. Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159c, 02-776 Warsaw, Poland.
Abstract
Background and Aim: Centroblastic lymphoma (CBL) is the most common morphological type of lymphoma found in dogs; it is usually identified through cytology in veterinary clinical practice. This study aimed to identify the demographic and clinical characteristics of dogs with CBL that was diagnosed with cytology and immunocytochemistry.
Materials and Methods: Dogs with a suspicion of lymphoma were diagnosed by cytology supported by immunocytochemistry with the use of the updated Kiel classification adapted for dogs. During the analyzed time period, 336 lymphomas were diagnosed in dogs, including 171 cases of CBL. Epidemiological and clinical data from the dogs with CBL were provisionally collected.
Results: The epidemiology analysis revealed an increased risk of CBL in Rottweilers, golden retrievers, and Bernese mountain dogs. At admission, most of the dogs displayed generalized lymphadenopathy with spleen and liver enlargement. The most common hematological abnormality was leukocytosis due to neutrophilia. The most common biochemical abnormality was elevated alanine aminotransferase and alkaline phosphatase activities and selective hypoproteinemia due to hypoalbuminemia.
Conclusion: Rottweilers, Bernese mountain dogs, and golden retrievers appear to be overrepresented among dogs with CBL. CBL is usually diagnosed at an advanced clinical stage according to the World Health Organization; however, it is usually accompanied by only minor hematological and biochemical abnormalities.
Funder
Szkola Glówna Gospodarstwa Wiejskiego w Warszawie
Publisher
Veterinary World
Subject
General Veterinary
Reference31 articles.
1. Greenlee, P.G., Filippa, D.A., Quimby, F.W., Patnaik, A.K., Calvano, S.E., Matus, R.E., Kimmel, M., Hurvitz, A.I. and Lieberman, P.H. (1990) Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer, 66(3): 480-490. 2. Teske, E.,Van Heerde, P., Rutteman, G.R., Kurzman, I.D., Moore, P.F. and MacEwen, E.G. (1994) Prognostic factors for treatment of malignant lymphoma in dogs. J. Am. Vet. Med. Assoc., 205(12): 1722-1728. 3. Fournel-Fleury, C., Magnol, J.P., Bricaire, P., Marchal, T., Chabanne, L., Delverdier, A., Bryon, P.A. and Felman, P. (1997) Cytohistologicaland immunological classification of canine malignant lymphomas. Comparison with human non-Hodgkin’s lymphomas. J. Comp. Pathol., 117(1): 35-39. 4. Ponce, F., Magnol, J.P., Ledieu, D., Marchal, T., Turinelli, V., Chalvet-Monfray, K. and Fournel-Fleury, C. (2004) Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet. J., 167(2): 158-166. 5. Ponce, F., Marchal, T., Magnol, J.P., Turinelli, V., Ledieu, D., Bonnefont, C., Pastor, M., Delignette, M.L. and Fournel-Fleury, C. (2010) A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet. Pathol., 47(3): 414-433.
|
|